(Q35101309)

6 August 2017

Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program (English)

1 reference

Diabetes Prevention Program Research Group

6 August 2017

1 reference

1 reference

9

object named as

Diabetes Prevention Program Research Group

1 reference

6 August 2017

8

William C Knowler

1 reference

6 August 2017

Jonathan Krakoff

1

1 reference

6 August 2017

Jeanne M Clark

2

1 reference

6 August 2017

Jill P Crandall

3

1 reference

6 August 2017

Charlton Wilson

4

1 reference

6 August 2017

Mark E Molitch

5

1 reference

6 August 2017

Frederick L Brancati

6

1 reference

6 August 2017

Sharon L Edelstein

7

1 reference

6 August 2017

25 February 2010

1 reference

6 August 2017

1 reference

6 August 2017

18

1 reference

6 August 2017

9

1 reference

6 August 2017

1762-1767

1 reference

Biomarkers of body iron stores and risk of developing type 2 diabetes

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The epidemiology of nonalcoholic fatty liver disease in adults

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Weight loss as a treatment for nonalcoholic fatty liver disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Hemochromatosis and iron-overload screening in a racially diverse population.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Metformin reverses fatty liver disease in obese, leptin-deficient mice

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Effect of metformin on food intake in obese subjects.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Estimates of nutrient intake from a food frequency questionnaire: the 1987 National Health Interview Survey

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The prevalence and etiology of elevated aminotransferase levels in the United States

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Modulation of hunger by plasma glucose and metformin.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Metformin in non-alcoholic steatohepatitis.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

Association of nonalcoholic fatty liver disease with insulin resistance.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

27 September 2018

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3135003

16 November 2018

https://api.crossref.org/works/10.1038%2FOBY.2010.21

31 March 2020

https://pubmed.ncbi.nlm.nih.gov/20186137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FOBY.2010.21

31 March 2020

Identifiers

DOI

10.1038/OBY.2010.21

1 reference

6 August 2017

1 reference

6 August 2017

1 reference